Actively Recruiting

Early Phase 1
Age: 18Years - 40Years
All Genders
Healthy Volunteers
NCT07030725

Menthol Stimulation of Brown Adipose Tissue in Humans: Aim 1

Led by Indiana University · Updated on 2025-06-25

24

Participants Needed

1

Research Sites

74 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Brown adipose tissue becomes activated during cold conditions to increase thermogenesis (i.e., energy expenditure). Topical menthol application increases resting energy expenditure but it is unclear whether brown adipose tissue activation contributes to this rise in the energy expenditure. The overall goal with this project is to determine whether topical menthol application stimulates brown adipose tissue.

CONDITIONS

Official Title

Menthol Stimulation of Brown Adipose Tissue in Humans: Aim 1

Who Can Participate

Age: 18Years - 40Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Fluent in English
  • Participate in 150 minutes or more of at least moderate intensity exercise per week during the previous year
  • Body fat 30% or less as determined by DEXA scan
  • Cleared for physical activity according to the 2020 Physical Activity Readiness Questionnaire (PAR-Q+)
Not Eligible

You will not qualify if you...

  • Any autonomic cardiovascular, metabolic, neurologic, endocrine, or respiratory disease deemed exclusionary by the investigator
  • Previously diagnosed liver or kidney dysfunction including acute or chronic kidney disease, cirrhosis, hepatitis, or fatty liver disease
  • Women who are pregnant or breastfeeding
  • Current or regular tobacco or electronic cigarette use more than twice a week in the past year
  • History of peripheral cold injury, skin disorders such as eczema or psoriasis, or excessive tattooing
  • Known chronic or acute conditions of the rectum
  • Allergy to menthol
  • Use of medications with direct effects on the cardiovascular system including anticoagulants, antiplatelet agents, ACE inhibitors, angiotensin II receptor blockers, angiotensin-receptor neprilysin inhibitors, beta blockers, calcium/potassium/sodium channel blockers, cholesterol lowering medications, digitalis preparations, diuretics, vasodilators, or anticholinergics

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Indiana University

Bloomington, Indiana, United States, 47405

Actively Recruiting

Loading map...

Research Team

F

Felipe Pereira, MS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

BASIC_SCIENCE

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here